Sky's The Limit On Savings For New NIH-Funded Innovative Trials Center
This article was originally published in The Pink Sheet Daily
Savings from using a master contract on NIH trials may be realized right away, but the network has potential for much more disruptive changes, says Duke Clinical Research Institute, which is running the new network with Vanderbilt.
You may also be interested in...
Publication in NEJM of results from Phase II of master protocol study of breast cancer combinations also helps build support for Bayesian statistics.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
A review by a government watchdog found the FDA’s review process for COVID-19 diagnostics was plagued by issues including allowing low-quality tests to slip through, high reviewer workloads, and manufacturer frustration.